INKT
#4294
MiNK Therapeutics, Inc. - Common Stock
10.7 4 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.46%
Monthly Change
-7.33%
6 month change
-2.36%
Year Change
-2.36%
Previous Close
10.7 9
Open
10.7 4
Low
10.7 4
High
10.7 4
Volume
1
Financials
- Market Capitalization 53.51 M
- Employee 15
- Founded 2017
- CEO N/A
- Website www.minktherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG012J84VS3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.76
Price to sales ratio
190.09
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4268 |  CNTX Context Therapeutics Inc. - Common Stock | 0.60 USD | -14.29% | -1.64% | -64.29% | -7.69% | 55.13 M USD | ||
| 4280 |  BOLD Boundless Bio, Inc. - Common Stock | 2.44 USD | -2.40% | -1.61% | +68.28% | +110.34% | 54.81 M USD | ||
| 4304 |  TIL Instil Bio, Inc. - Common Stock | 7.79 USD | +0.52% | +1.30% | -4.42% | -60.03% | 52.83 M USD | ||
| 4308 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.28 USD | -0.32% | +3.00% | +21.78% | +1188.89% | 53.66 M USD |
Frequently asked questions about MiNK Therapeutics, Inc. - Common Stock
What is the MiNK Therapeutics, Inc. - Common Stock stock price today?
The current price of MiNK Therapeutics, Inc. - Common Stock (INKT) is 10.74. Over the past 24 hours, the stock has changed by -0.46%. Follow the INKT chart for real-time price dynamics.
What is the stock ticker of MiNK Therapeutics, Inc. - Common Stock?
MiNK Therapeutics, Inc. - Common Stock trades under the ticker INKT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MiNK Therapeutics, Inc. - Common Stock stock going up?
INKT has changed by -6.28% over the last week, -7.33% over the last month, and -2.36% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MiNK Therapeutics, Inc. - Common Stock net income for the last quarter?
MiNK Therapeutics, Inc. - Common Stock reported net income of -2.74 M for the last quarter. The previous quarter showed -2.6 M, which means net income changed by -5.39%.
How many employees does MiNK Therapeutics, Inc. - Common Stock have?
As of the latest available data, MiNK Therapeutics, Inc. - Common Stock has 15 employees. Workforce size can provide additional context about the company's scale and operations.
What is MiNK Therapeutics, Inc. - Common Stock EBITDA?
MiNK Therapeutics, Inc. - Common Stock EBITDA is -1.56 M, and its EBITDA margin is -1 930.87%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MiNK Therapeutics, Inc. - Common Stock stock?
You can buy MiNK Therapeutics, Inc. - Common Stock (INKT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MiNK Therapeutics, Inc. - Common Stock stock?
Investing in MiNK Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INKT chart and related analysis on metatrader.com as part of your research.